Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89.9M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
59.7M
-
Shares change
-
+3.1M
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
+$84.4M
-
Put/Call ratio
-
1.1
-
Number of buys
-
77
-
Number of sells
-
-51
-
Price
-
$26.98
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q3 2023
159 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q3 2023.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.7M shares
of 89.9M outstanding shares and own 66.37% of the company stock.
Largest 10 shareholders include BVF INC/IL (5.28M shares), BlackRock Inc. (4.59M shares), FEDERATED HERMES, INC. (3.38M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.03M shares), VANGUARD GROUP INC (2.97M shares), Canaan Partners X LLC (2.66M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.29M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.27M shares), Logos Global Management LP (2.25M shares), and Boxer Capital, LLC (2.2M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.